These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27514759)

  • 1. Weight loss induced by bariatric surgery restores adipose tissue PNPLA3 expression.
    Wieser V; Adolph TE; Enrich B; Moser P; Moschen AR; Tilg H
    Liver Int; 2017 Feb; 37(2):299-306. PubMed ID: 27514759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
    Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
    Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3.
    Lallukka S; Sevastianova K; Perttilä J; Hakkarainen A; Orho-Melander M; Lundbom N; Olkkonen VM; Yki-Järvinen H
    Diabetologia; 2013 Apr; 56(4):886-92. PubMed ID: 23334462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight Loss Induced by Bariatric Surgery Restricts Hepatic
    Adolph TE; Grabherr F; Mayr L; Grander C; Enrich B; Moschen AR; Tilg H
    J Obes; 2018; 2018():7108075. PubMed ID: 30533221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans.
    Sevastianova K; Kotronen A; Gastaldelli A; Perttilä J; Hakkarainen A; Lundbom J; Suojanen L; Orho-Melander M; Lundbom N; Ferrannini E; Rissanen A; Olkkonen VM; Yki-Järvinen H
    Am J Clin Nutr; 2011 Jul; 94(1):104-11. PubMed ID: 21525193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
    Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
    Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
    Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression.
    Moschen AR; Molnar C; Geiger S; Graziadei I; Ebenbichler CF; Weiss H; Kaser S; Kaser A; Tilg H
    Gut; 2010 Sep; 59(9):1259-64. PubMed ID: 20660075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric banding-associated weight loss diminishes hepatic Tsukushi expression.
    Grander C; Jaschke N; Enrich B; Grabherr F; Mayr L; Schwärzler J; Effenberger M; Adolph TE; Tilg H
    Cytokine; 2020 Sep; 133():155114. PubMed ID: 32442908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes.
    Karamfilova V; Gateva A; Assyov Y; Alexiev A; Savov A; Yaneva N; Ivanova I; Ivanova-Boyanova R; Ivanova R; Vlahova Z; Mateva L; Kamenov Z
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):433-438. PubMed ID: 31826069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
    Donati B; Motta BM; Pingitore P; Meroni M; Pietrelli A; Alisi A; Petta S; Xing C; Dongiovanni P; del Menico B; Rametta R; Mancina RM; Badiali S; Fracanzani AL; Craxì A; Fargion S; Nobili V; Romeo S; Valenti L
    Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
    Guichelaar MM; Gawrieh S; Olivier M; Viker K; Krishnan A; Sanderson S; Malinchoc M; Watt KD; Swain JM; Sarr M; Charlton MR
    Obesity (Silver Spring); 2013 Sep; 21(9):1935-41. PubMed ID: 23418085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
    Xia MF; Ling Y; Bian H; Lin HD; Yan HM; Chang XX; Li XM; Ma H; Wang D; Zhang LS; Wang SS; Wu BJ; He WY; Zhao NQ; Gao X
    Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes.
    Xia MF; Lin HD; Chen LY; Wu L; Ma H; Li Q; Aleteng Q; Hu Y; He WY; Gao J; Bian H; Li XY; Gao X
    Diabetologia; 2019 Apr; 62(4):644-654. PubMed ID: 30673802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans.
    Lallukka S; Luukkonen PK; Zhou Y; Isokuortti E; Leivonen M; Juuti A; Hakkarainen A; Orho-Melander M; Lundbom N; Olkkonen VM; Lassila R; Yki-Järvinen H
    Thromb Haemost; 2017 Jan; 117(2):286-294. PubMed ID: 27929200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patatin-Like Phospholipase Domain-Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population.
    Unalp-Arida A; Ruhl CE
    Hepatology; 2020 Mar; 71(3):820-834. PubMed ID: 31705824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.
    Zhou Y; Llauradó G; Orešič M; Hyötyläinen T; Orho-Melander M; Yki-Järvinen H
    J Hepatol; 2015 Mar; 62(3):657-63. PubMed ID: 25457209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
    Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL
    Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease.
    Chen W; Chang B; Li L; Chan L
    Hepatology; 2010 Sep; 52(3):1134-42. PubMed ID: 20648554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.